Robert J. Hugin

Bob Hugin is a veteran biopharmaceutical executive with a proven track record of leadership and value creation. He is the former Chairman and Chief Executive Officer of Celgene Corporation, a global biopharmaceutical company recognized for developing transformational therapies for serious unmet medical needs. During his tenure, Celgene became a leader in oncology, immunology, and inflammation. Mr. Hugin previously served as Chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA), representing the U.S. biopharmaceutical industry on policy and regulatory issues. He currently serves as a director of Biohaven Pharmaceuticals, Chubb Limited and the Parker Institute for Cancer Immunotherapy, where he contributes strategic insight across drug development, clinical innovation, and corporate growth. Earlier in his career, Mr. Hugin was a Managing Director at J.P. Morgan. He holds a Bachelor of Arts from Princeton University and an MBA from the Darden School of Business, University of Virginia.